Načítá se...
Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering
Recent advances in the field of cellular therapy have focused on autologous T cells engineered to express a chimeric antigen receptor (CAR) against tumor antigens. Remarkable responses have been observed in patients receiving autologous CD19- redirected T cells for the treatment B-lymphoid malignanc...
Uloženo v:
| Vydáno v: | Curr Opin Immunol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6140331/ https://ncbi.nlm.nih.gov/pubmed/29605760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coi.2018.03.013 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|